4.6 Article

FGF/FGFR2 Signaling Regulates the Generation and Correct Positioning of Bergmann Glia Cells in the Developing Mouse Cerebellum

期刊

PLOS ONE
卷 9, 期 7, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0101124

关键词

-

资金

  1. EU grant 'Systems Biology of Stem Cells and Reprogramming' (SyBoSS) [FP7-Health-F4-2010-2421291]
  2. Helmholtz Alliance HeIMA-Helmholtz Alliance for Mental Health in an Ageing Society, through the Initiative and Network Fund of the Helmholtz Association
  3. Bundesministerium fur Bildung und Forschung in the DiGtoP consortium [FKZ01GS0858]
  4. BMBF in the network 'Neurogenesis from brain and skin cells' [01GN1009C]

向作者/读者索取更多资源

The normal cellular organization and layering of the vertebrate cerebellum is established during embryonic and early postnatal development by the interplay of a complex array of genetic and signaling pathways. Disruption of these processes and of the proper layering of the cerebellum usually leads to ataxic behaviors. Here, we analyzed the relative contribution of Fibroblast growth factor receptor 2 (FGFR2)-mediated signaling to cerebellar development in conditional Fgfr2 single mutant mice. We show that during embryonic mouse development, Fgfr2 expression is higher in the anterior cerebellar primordium and excluded from the proliferative ventricular neuroepithelium. Consistent with this finding, conditional Fgfr2 single mutant mice display the most prominent defects in the anterior lobules of the adult cerebellum. In this context, FGFR2-mediated signaling is required for the proper generation of Bergmann glia cells and the correct positioning of these cells within the Purkinje cell layer, and for cell survival in the developing cerebellar primordium. Using cerebellar microexplant cultures treated with an FGFR agonist (FGF9) or antagonist (SU5402), we also show that FGF9/FGFR-mediated signaling inhibits the outward migration of radial glia and Bergmann glia precursors and cells, and might thus act as a positioning cue for these cells. Altogether, our findings reveal the specific functions of the FGFR2-mediated signaling pathway in the generation and positioning of Bergmann glia cells during cerebellar development in the mouse.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Precise CRISPR-Cas-mediated gene repair with minimal off-target and unintended on-target mutations in human hematopoietic stem cells

Ngoc Tung Tran, Eric Danner, Xun Li, Robin Graf, Mikhail Lebedin, Kathrin de la Rosa, Ralf Kuehn, Klaus Rajewsky, Van Trung Chu

Summary: This study establishes a spacer-nick gene correction approach that combines Cas9D10A nickase with a pair of PAM-out sgRNAs, resulting in efficient gene correction with reduced off-target mutations. The results suggest that this approach provides improved safety and suitability for gene therapy.

SCIENCE ADVANCES (2022)

Article Oncology

A RAS-Independent Biomarker Panel to Reliably Predict Response to MEK Inhibition in Colorectal Cancer

Ulrike Pfohl, Juergen Loskutov, Sanum Bashir, Ralf Kuhn, Patrick Herter, Markus Templin, Soulafa Mamlouk, Sergei Belanov, Michael Linnebacher, Florian Buertin, Marcus Vetter, Christoph Reinhard, Lena Wedeken, Christian R. A. Regenbrecht

Summary: This research investigated the impact of loss-of-function of the SMAD4 gene on the sensitivity to MEK inhibitors in colorectal cancer using CRISPR technology. It identified a mutation signature related to the TGF-beta/BMP signaling pathway and found a gene signature (SFAB) that can predict sensitivity to MEK inhibitors.

CANCERS (2022)

Article Veterinary Sciences

Improving biomedical research by automated behaviour monitoring in the animal home cage - action needed for networking

Sabine M. Hoelter, Sara Wells, Vootele Voikar

Summary: The key goal in biomedical research is to understand the causes of diseases and develop strategies for prevention and effective therapies. Concerns have been raised about the reproducibility and translational validity of preclinical research in animal models. Automated behavior monitoring in the animal's home cage is a promising solution to improve the validity and translatability of animal studies.

LABORATORY ANIMALS (2023)

Article Biology

Genome-wide screening reveals the genetic basis of mammalian embryonic eye development

Justine Chee, Louise Lanoue, Dave L. Clary, Kendall Higgins, Lynette Bower, Ann Flenniken, Ruolin Guo, David Adams, Fatima Bosch, Robert E. Braun, Steve D. M. Brown, H. -J. Genie Chin, Mary Dickinson, Chih-Wei Hsu, Michael Dobbie, Xiang Gao, Sanjeev Galande, Anne Grobler, Jason Heaney, Yann Herault, Martin Hrabe de Angelis, Fabio Mammano, Lauryl M. J. Nutter, Helen Parkinson, Chuan Qin, Toshi Shiroishi, Radislav Sedlacek, J-K Seong, Ying Xu, Brian Brooks, Colin McKerlie, K. C. Kent Lloyd, Henrik Westerberg, Ala Moshiri

Summary: This study identified new genes and pathways associated with eye development through screening of mouse genes. These findings provide insights into the molecular and cellular mechanisms of eye development and could potentially contribute to the diagnosis and treatment of congenital blinding diseases.

BMC BIOLOGY (2023)

Article Medicine, General & Internal

Recommendations for robust and reproducible preclinical research in personalised medicine

Vibeke Fosse, Emanuela Oldoni, Florence Bietrix, Alfredo Budillon, Evangelos P. Daskalopoulos, Maddalena Fratelli, Bjoern Gerlach, Peter M. A. Groenen, Sabine M. Holter, Julia M. L. Menon, Ali Mobasheri, Nikki Osborne, Merel Ritskes-Hoitinga, Bettina Ryll, Elmar Schmitt, Anton Ussi, Antonio L. Andreu, Emmet McCormack

Summary: Personalized medicine aims to provide tailor-made prevention and treatment strategies for specific groups, but there are challenges in clinical relevance and model validity. Researchers have developed a set of recommendations to improve the robustness of preclinical methods in translational research for personalized medicine through literature review, expert discussions, and consensus meetings.

BMC MEDICINE (2023)

Article Biochemistry & Molecular Biology

A rationale for considering heart/brain axis control in neuropsychiatric disease

Lillian Garrett, Dietrich Truembach, Nadine Spielmann, Wolfgang Wurst, Helmut Fuchs, Valerie Gailus-Durner, Martin Hrabe De Angelis, Sabine M. Hoelter

Summary: Neuropsychiatric diseases represent a significant global disease burden and require innovative approaches for pathogenic understanding, biomarker identification, and therapeutic strategies. The malfunction of the heart/brain axis, particularly through the autonomic nervous system and brain central autonomic network interaction, plays a crucial role in the etiology of these diseases. This inter-relationship offers potential avenues for novel diagnosis and treatment approaches.

MAMMALIAN GENOME (2023)

Article Immunology

IFNγ binding to extracellular matrix prevents fatal systemic toxicity

Josephine Kemna, Evelyne Gout, Leon Daniau, Jessica Lao, Kristoffer Weissert, Sandra Ammann, Ralf Kuehn, Matthias Richter, Christine Molenda, Anje Sporbert, Dario Zocholl, Robert Klopfleisch, Hugues Lortat-Jacob, Peter Aichele, Thomas Kammertoens, Thomas Blankenstein

Summary: The study demonstrates that the extracellular matrix (ECM)-binding domain (EBD) of interferon-gamma (IFN gamma) is crucial for preventing high systemic levels of this cytokine and related immunopathology. Lack of EBD in IFN gamma significantly reduces ECM binding but retains the binding to IFN gamma receptor and bioactivity. Overexpression of EBD-deficient IFN gamma results in increased systemic levels, sickness behavior, weight loss, and toxicity.

NATURE IMMUNOLOGY (2023)

Article Multidisciplinary Sciences

New C3H KitN824K/WT cancer mouse model develops late-onset malignant mammary tumors with high penetrance

Tanja Klein-Rodewald, Kateryna Micklich, Adrian Sanz-Moreno, Monica Tost, Julia Calzada-Wack, Thure Adler, Matthias Klaften, Sibylle Sabrautzki, Bernhard Aigner, Markus Kraiger, Valerie Gailus-Durner, Helmut Fuchs, Albert Gruender, Heike Pahl, Eckhard Wolf, Martin Hrabe de Angelis, Birgit Rathkolb

Summary: Gastro-intestinal stromal tumors and acute myeloid leukemia induced by activating stem cell factor receptor tyrosine kinase (KIT) mutations are highly malignant. The role of KIT mutations in breast cancer is unclear. Treatment success of KIT-induced cancers is still unsatisfactory due to resistance to therapy. Mouse models offer essential platforms for studies on molecular disease mechanisms. The C3H Kit(N824K/WT) mouse model allows for investigating the role of KIT mutations in breast cancer and identifying genetic and environmental modifiers of disease progression.

SCIENTIFIC REPORTS (2022)

Article Endocrinology & Metabolism

Validation of Mct8/Oatp1c1 dKO mice as a model organism for the Allan-Herndon-Dudley Syndrome

Gandhari Maity-Kumar, Lisa Staender, Meri DeAngelis, Sooyeon Lee, Anna Molenaar, Lore Becker, Lillian Garrett, Oana Amerie, Sabine M. Hoelter, Wolfgang Wurst, Helmut Fuchs, Annette Feuchtinger, Valerie Gailus-Durner, Cristina Garcia-Caceres, Ahmed E. Othman, Caroline Brockmann, Vanessa Schoeffling, Katja Beiser, Heiko Krude, Piotr A. Mroz, Susanna Hofmann, Jan Tuckermann, Richard D. DiMarchi, Martin Hrabe de Angelis, Matthias H. Tschoep, Paul T. Pfluger, Timo D. Mueller

Summary: In this study, researchers generated a new Mct8/Oatp1c1 double-knockout mouse model and demonstrated that this model could mimic key features of the Allan-Herndon-Dudley syndrome (AHDS). The findings suggest that the Mct8/Oatp1c1 dKO mice are a valuable preclinical model for evaluating drugs for the treatment of AHDS.

MOLECULAR METABOLISM (2022)

Article Biology

Branch point strength controls species-specific CAMK2B alternative splicing and regulates LTP

Andreas Franz, A. Ioana Weber, Marco Preussner, Nicole Dimos, Alexander Stumpf, Yanlong Ji, Laura Moreno-Velasquez, Anne Voigt, Frederic Schulz, Alexander Neumann, Benno Kuropka, Ralf Kuehn, Henning Urlaub, Dietmar Schmitz, Markus C. Wahl, Florian Heyd

Summary: This study investigates the regulation and functionality of species-specific alternative splicing, focusing on CAMK2B splice isoforms in primates. The researchers identify and characterize several primate-specific CAMK2B splice isoforms with altered kinetic properties and substrate specificity. They demonstrate that primate-specific CAMK2B alternative splicing is achieved through branch point weakening during evolution. By introducing a weaker branch point sequence into the mouse genome, they observe significant changes in Camk2b splicing and impairment of long-term potentiation, linking branch point-controlled CAMK2B alternative splicing to learning and memory.

LIFE SCIENCE ALLIANCE (2022)

Article Biochemistry & Molecular Biology

Knockout mouse models as a resource for the study of rare diseases

Patricia da Silva-Buttkus, Nadine Spielmann, Tanja Klein-Rodewald, Christine Schuett, Antonio Aguilar-Pimentel, Oana V. Amarie, Lore Becker, Julia Calzada-Wack, Lillian Garrett, Raffaele Gerlini, Markus Kraiger, Stefanie Leuchtenberger, Manuela A. Oestereicher, Birgit Rathkolb, Adrian Sanz-Moreno, Claudia Stoeger, Sabine M. Hoelter, Claudia Seisenberger, Susan Marschall, Helmut Fuchs, Valerie Gailus-Durner, Martin Hrabe de Angelis

Summary: Rare diseases pose challenges in medicine due to their diverse clinical manifestations and low prevalence. The lack of specific treatments for the majority of rare diseases highlights the need for research. Genome sequencing technology allows for the identification of potential disease-causing genes, but further confirmation is required. Mouse knockout models are crucial for studying the genetics of rare diseases and the German Mouse Clinic is a pioneer in this field. Collaboration between research institutions, clinicians, and patient groups is necessary to advance the understanding and treatment of rare diseases.

MAMMALIAN GENOME (2023)

Correction Immunology

IFNγ binding to extracellular matrix prevents fatal systemic toxicity (vol 24, pg 414, 2023)

Josephine Kemna, Evelyne Gout, Leon Daniau, Jessica Lao, Kristoffer Weissert, Sandra Ammann, Ralf Kuehn, Matthias Richter, Christine Molenda, Anje Sporbert, Dario Zocholl, Robert Klopfleisch, Hugues Lortat-Jacob, Peter Aichele, Thomas Kammertoens, Thomas Blankenstein

NATURE IMMUNOLOGY (2023)

Article Biology

Deletion of SERF2 in mice delays embryonic development and alters amyloid deposit structure in the brain

Esther Stroo, Leen Janssen, Olga Sin, Wytse Hogewerf, Mirjam Koster, Liesbeth Harkema, Sameh A. Youssef, Natalie Beschorner, Anouk H. G. Wolters, Bjorn Bakker, Lore Becker, Lilian Garrett, Susan Marschall, Sabine M. Hoelter, Wolfgang Wurst, Helmut Fuchs, Valerie Gailus-Durner, Martin Hrabe de Angelis, Amanth Thathiah, Floris Foijer, Bart van de Sluis, Jan van Deursen, Matthias Jucker, Alain de Brun, Ellen A. A. Nollen

Summary: In age-related neurodegenerative diseases, disease-specific proteins form amyloid-like deposits. Depletion of SERF proteins can ameliorate this process. However, it is unknown whether SERF modifies amyloid pathology in mammalian brain.

LIFE SCIENCE ALLIANCE (2023)

Article Biochemistry & Molecular Biology

AOX delays the onset of the lethal phenotype in a mouse model of Uqcrh (complex III) disease

Howard T. Jacobs, Marten Szibor, Birgit Rathkolb, Patricia da Silva-Buttkus, Juan Antonio Aguilar-Pimentel, Oana V. Amarie, Lore Becker, Julia Calzada-Wack, Nathalia Dragano, Lillian Garrett, Raffaele Gerlini, Sabine M. Hoelter, Tanja Klein-Rodewald, Markus Kraiger, Stefanie Leuchtenberger, Susan Marschall, Manuela A. Oestereicher, Kristina Pfannes, Adrian Sanz-Moreno, Claudia Seisenberger, Nadine Spielmann, Claudia Stoeger, Wolfgang Wurst, Helmut Fuchs, Martin Hrabe de Angelis, Valerie Gailus-Durner

Summary: The alternative oxidase (AOX) can delay the onset and progression of respiratory-chain diseases, but it does not provide long-term benefit.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2023)

暂无数据